What is the Medicines Transparency Alliance? How does it work? What has it achieved?
'Effecting Change': the MeTA Annual Review 2009-2010
A review of the activity, challenges and achievements across the pilot countries from June 2009 to May 2010.
Levelling the playing field - Report
This is a report of a consultative meeting with over 30 representatives from the pharmaceutical sector, which took place in London on 23 June, 2009.
Core principles of MeTA
These core principles underpin the approach of the Medicines Transparency Alliance (MeTA). Signing up to them is an important first step for any stakeholders wishing to engage in the MeTA process.
Laying the foundations
Medicines Transparency Alliance Annual Review 2008-2009
Implementing our pilot phase - briefing paper
A four-page summary of the report of the same name. This is a brief introduction to MeTA, how it works and and what is proposed for the pilot phase.
What is Transparency?
In financial and political terms ‘transparency’ has come to mean the full, clear and timely disclosure of relevant information, that in turn makes for easier understanding and encourages public scrutiny of processes and practices.